| 1 |
31685786 | Treatment with Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp+CD4+ Cell-related Pathogenesis in a Representative Patient with Refractory Proliferative Lupus Nephritis. | 2019 |
1 |
| 2 |
28626187 | Efficacy of Intravenous Cyclophosphamide Pulse Therapy for P-Glycoprotein-expressing B Cell-associated Active True Renal Lupus Vasculitis in Lupus Nephritis. | 2017 |
1 |
| 3 |
25989890 | Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy. | 2015 Apr |
1 |
| 4 |
25087953 | Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cells. | 2014 |
3 |
| 5 |
25251877 | Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis. | 2014 Dec |
5 |
| 6 |
24617050 | P-glycoprotein-1 functional activity in CD5+CD7+ and CD20+ lymphocytes in systemic lupus erythematosus children: relation to disease activity, complications and steroid response. | 2013 |
1 |
| 7 |
22380717 | Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. | 2012 Sep |
2 |
| 8 |
22543673 | Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy. | 2012 Sep |
1 |
| 9 |
23170130 | Detection of active P-glycoprotein in systemic lupus erythematosus patients with poor disease control. | 2012 Oct |
1 |
| 10 |
20041327 | PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. | 2010 Sep |
2 |
| 11 |
17164692 | Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin. | 2006 Dec |
1 |
| 12 |
15703814 | Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. | 2005 Mar |
1 |
| 13 |
14671431 | The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2. | 2003 Dec |
1 |
| 14 |
10897619 | [Resistance to therapy in primary nephrotic syndrome: effect of MDR1 gene activity]. | 2000 Apr |
1 |
| 15 |
9116319 | P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer. | 1997 Jan |
1 |
| 16 |
7903668 | Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy. | 1993 |
2 |
| 17 |
8251651 | Expression of mdr1 gene in human breast primary tumors and metastases. | 1993 |
1 |
| 18 |
1357834 | The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. | 1992 Jun |
1 |
| 19 |
1682037 | P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. | 1991 Nov 1 |
1 |